MRCCC Competitors

Peter MacCallum Cancer Centre (‘Peter Mac’) is a world leading cancer research, education and treatment centre and Australia’s only public health service dedicated to caring for people affected by cancer. With more than 4,000 employees, including 700+ laboratory and clinical researchers, we’re focused on providing better treatments, better care and potential cures for cancer. Our values are Compassion, Excellence and Innovation. We offer a range of staff benefits which support our people both personally and professionally, including: • Up to $11,660 in salary packaging to increase your take home pay • Discounted health insurance and eye care • A comprehensive health and wellbeing program • Pathways for professional development and career opportunities • Flexible working arrangements wherever possible • Up to six weeks annual leave plus additional purchased leave Our main site in Parkville, Melbourne, a state-of-the-art, purpose-built facility, offers public transport options at our doorstep and end of trip facilities for cyclists, along with onsite eateries, coffee shops and relaxing rooftop garden spaces. We also have six additional sites providing radiation therapy services to patients in Moorabbin, Box Hill, Bendigo and Sunshine, plus our imaging centre in East Melbourne. Peter Mac celebrates, values and supports a diverse and inclusive environment that reflects our vibrant community. We encourage job applications from anyone identifying as Aboriginal and/or Torres Strait Islander. We also welcome anyone who identifies as LGBTQIA+, linguistically, culturally and/or gender diverse, people with disability, and people of any age to apply for our roles. Join us and break new ground and change lives. Peter Mac acknowledges the Traditional Owners of the land on which our sites are located throughout Victoria. We recognise their strength and resilience and pay our respects to their Elders past and present.

We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Since our inception, the MMRF has committed over $600 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.

The Leukaemia Foundation is the only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life. It exists only because of the generous and ongoing support of the Australian community. Leukaemia, lymphoma and myeloma are all types of blood cancer and they can develop in anyone, of any age, at any time. Another 53 Australians are diagnosed each and every day. Although improved treatments and care are helping more people survive, sadly someone loses their life to blood cancer every two hours. In fact, blood cancer combined is the second most commonly diagnosed cancer in Australia, and the second most common cause of cancer death, claiming more lives than breast cancer and melanoma combined. Learn more about blood cancer and how you can beat it at leukaemia.org.au.